Overview

Trial to Evaluate Efficacy and Safety of Nitazoxanide in the Treatment of Mild or Moderate COVID-19

Status:
Completed
Trial end date:
2021-02-08
Target enrollment:
Participant gender:
Summary
Trial to Evaluate Efficacy and Safety of Nitazoxanide in the Treatment of Mild or Moderate COVID-19
Phase:
Phase 3
Details
Lead Sponsor:
Romark Laboratories L.C.
Treatments:
Nitazoxanide